Atlas Trials

A Study of SHR6390 in Advanced Solid Tumor Patients

Clinical trial NCT02684266 · COMPLETED

Trial details

NCT number
NCT02684266
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasm
Start date
2016-03-03
Primary completion
2019-06-28
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.